Tubacin, the other miscellaneous HDAC inhibitor, is a specific for HDAC6[75] and it has been proposed to be useful because HDAC6 is known to be increased in certain high-grade gliomas. This evidence concerns the gene HDAC6 and central nervous system cancer.